{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:10:56Z","timestamp":1789031456094,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,10]]},"DOI":"10.7759\/cureus.116037","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:55:54Z","timestamp":1789030554000},"source":"Crossref","is-referenced-by-count":0,"title":["Profile of Invasive Fungal Infections in a Paediatric Haemato-Oncology Unit: A Five-Year Retrospective Cohort Study From a Tertiary Care Centre in South India"],"prefix":"10.7759","author":[{"given":"Rishab","family":"Bhurat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Harish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha","family":"Sneha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmasani","family":"Venkat Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanthi","family":"Mariappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajoo","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000003035","article-title":"Invasive fungal infections in pediatric hematology-oncology: a 12-year single-center observational study and the need for a clinical classification system","volume":"47","author":"Tanriver U","year":"2025","unstructured":"Tanriver U, Hutter A, Kohns M, von der Weid N, Schifferli A. Invasive fungal infections in pediatric hematology-oncology: a 12-year single-center observational study and the need for a clinical classification system. J Pediatr Hematol Oncol. 2025, 47:e192-8. 10.1097\/MPH.0000000000003035","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly JP","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, et al.. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020, 71:1367-76. 10.1093\/cid\/ciz1008","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30723-3","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Groll AH","year":"2021","unstructured":"Groll AH, Pana D, Lanternier F, et al.. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation. Lancet Oncol. 2021, 22:254-69. 10.1016\/S1470-2045(20)30723-3","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00158","article-title":"Clinical practice guideline for systemic antifungal prophylaxis in pediatric patients with cancer and hematopoietic stem-cell transplantation recipients","volume":"38","author":"Lehrnbecher T","year":"2020","unstructured":"Lehrnbecher T, Fisher BT, Phillips B, et al.. Clinical practice guideline for systemic antifungal prophylaxis in pediatric patients with cancer and hematopoietic stem-cell transplantation recipients. J Clin Oncol. 2020, 38:3205-16. 10.1200\/JCO.20.00158","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.05.019","article-title":"ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children","volume":"25","author":"Warris A","year":"2019","unstructured":"Warris A, Lehrnbecher T, Roilides E, Castagnola E, Br\u00fcggemann RJ, Groll AH. ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children. Clin Microbiol Infect. 2019, 25:1096-113. 10.1016\/j.cmi.2019.05.019","journal-title":"Clin Microbiol Infect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.18502\/CMM.6.2.2840","article-title":"Invasive fungal infections in a pediatric hematology-oncology department: a 16-year retrospective study","volume":"6","author":"Kazakou N","year":"2020","unstructured":"Kazakou N, Vyzantiadis TA, Gambeta A, et al.. Invasive fungal infections in a pediatric hematology-oncology department: a 16-year retrospective study. Curr Med Mycol. 2020, 6:37-42. 10.18502\/CMM.6.2.2840","journal-title":"Curr Med Mycol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-018-2722-0","article-title":"Prevalence and predictors of invasive fungal infections in children with persistent febrile neutropenia treated for acute leukemia - a prospective study","volume":"85","author":"Kumar J","year":"2018","unstructured":"Kumar J, Singh A, Seth R, Xess I, Jana M, Kabra SK. Prevalence and predictors of invasive fungal infections in children with persistent febrile neutropenia treated for acute leukemia - a prospective study. Indian J Pediatr. 2018, 85:1090-5. 10.1007\/s12098-018-2722-0","journal-title":"Indian J Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myy060","article-title":"A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment","volume":"57","author":"Prakash H","year":"2019","unstructured":"Prakash H, Ghosh AK, Rudramurthy SM, et al.. A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment. Med Mycol. 2019, 57:395-402. 10.1093\/mmy\/myy060","journal-title":"Med Mycol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update","volume":"6","author":"Skiada A","year":"2020","unstructured":"Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: an update. J Fungi (Basel). 2020, 6:265. 10.3390\/jof6040265","journal-title":"J Fungi (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9030523","article-title":"Epidemiology of mucormycosis in India","volume":"9","author":"Prakash H","year":"2021","unstructured":"Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms. 2021, 9:523. 10.3390\/microorganisms9030523","journal-title":"Microorganisms"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-007-6144-6","article-title":"Epidemiology of candidemia in a tertiary care centre of north India: 5-year study","volume":"35","author":"Xess I","year":"2007","unstructured":"Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection. 2007, 35:256-9. 10.1007\/s15010-007-6144-6","journal-title":"Infection"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/0255-0857.49440","article-title":"Epidemiology of Candida bloodstream infections in a tertiary care institute in India","volume":"27","author":"Kothari A","year":"2009","unstructured":"Kothari A, Sagar V. Epidemiology of Candida bloodstream infections in a tertiary care institute in India. Indian J Med Microbiol. 2009, 27:171-2. 10.4103\/0255-0857.49440","journal-title":"Indian J Med Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2015.06.006","article-title":"Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India","volume":"8","author":"Dewan E","year":"2015","unstructured":"Dewan E, Biswas D, Kakati B, Verma SK, Kotwal A, Oberoi A. Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India. Hematol Oncol Stem Cell Ther. 2015, 8:99-105. 10.1016\/j.hemonc.2015.06.006","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.4.1818-1828.2005","article-title":"Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature","volume":"43","author":"Girmenia C","year":"2005","unstructured":"Girmenia C, Pagano L, Martino B, et al.. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol. 2005, 43:1818-28. 10.1128\/JCM.43.4.1818-1828.2005","journal-title":"J Clin Microbiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2010.535179","article-title":"Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature","volume":"49","author":"Schuermans C","year":"2011","unstructured":"Schuermans C, van Bergen M, Coorevits L, Verhaegen J, Lagrou K, Surmont I, Jeurissen A. Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature. Med Mycol. 2011, 49:414-8. 10.3109\/13693786.2010.535179","journal-title":"Med Mycol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00345-17","article-title":"Diagnostic value of galactomannan antigen test in serum and bronchoalveolar lavage fluid samples from patients with nonneutropenic invasive pulmonary aspergillosis","volume":"55","author":"Zhou W","year":"2017","unstructured":"Zhou W, Li H, Zhang Y, et al.. Diagnostic value of galactomannan antigen test in serum and bronchoalveolar lavage fluid samples from patients with nonneutropenic invasive pulmonary aspergillosis. J Clin Microbiol. 2017, 55:2153-61. 10.1128\/JCM.00345-17","journal-title":"J Clin Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piv014","article-title":"(1\u21923)-\u03b2-D-glucan in cerebrospinal fluid as a biomarker for Candida and Aspergillus infections of the central nervous system in pediatric patients","volume":"5","author":"Salvatore CM","year":"2016","unstructured":"Salvatore CM, Chen TK, Toussi SS, DeLaMora P, Petraitiene R, Finkelman MA, Walsh TJ. (1\u21923)-\u03b2-D-glucan in cerebrospinal fluid as a biomarker for Candida and Aspergillus infections of the central nervous system in pediatric patients. J Pediatric Infect Dis Soc. 2016, 5:277-86. 10.1093\/jpids\/piv014","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.2110","article-title":"Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients","volume":"6","author":"Badiee P","year":"2012","unstructured":"Badiee P, Alborzi A, Karimi M, Pourabbas B, Haddadi P, Mardaneh J, Moieni M. Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients. J Infect Dev Ctries. 2012, 6:352-7. 10.3855\/jidc.2110","journal-title":"J Infect Dev Ctries"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20784","article-title":"Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary disease in children with primary immunodeficiency and cancer","volume":"48","author":"Efrati O","year":"2007","unstructured":"Efrati O, Gonik U, Bielorai B, et al.. Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary disease in children with primary immunodeficiency and cancer. Pediatr Blood Cancer. 2007, 48:324-9. 10.1002\/pbc.20784","journal-title":"Pediatr Blood Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23644","article-title":"Diagnostic yield of bronchoalveolar lavage in immunocompromised children with malignant and non-malignant disorders","volume":"52","author":"Nadimpalli S","year":"2017","unstructured":"Nadimpalli S, Foca M, Satwani P, Sulis ML, Constantinescu A, Saiman L. Diagnostic yield of bronchoalveolar lavage in immunocompromised children with malignant and non-malignant disorders. Pediatr Pulmonol. 2017, 52:820-6. 10.1002\/ppul.23644","journal-title":"Pediatr Pulmonol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely OA","year":"2007","unstructured":"Cornely OA, Maertens J, Winston DJ, et al.. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007, 356:348-59. 10.1056\/NEJMoa061094","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas PG","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, et al.. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016, 62:e1-50. 10.1093\/cid\/civ933","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson TF","year":"2016","unstructured":"Patterson TF, Thompson GR 3rd, Denning DW, et al.. Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016, 63:e1-60. 10.1093\/cid\/ciw326","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht R","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, et al.. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002, 347:408-15. 10.1056\/NEJMoa020191","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200203000-00015","article-title":"Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children","volume":"21","author":"Walsh TJ","year":"2002","unstructured":"Walsh TJ, Lutsar I, Driscoll T, et al.. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J. 2002, 21:240-8. 10.1097\/00006454-200203000-00015","journal-title":"Pediatr Infect Dis J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000128781.77600.6f","article-title":"Risk factors for disseminated candidiasis in children with candidemia","volume":"23","author":"Zaoutis TE","year":"2004","unstructured":"Zaoutis TE, Greves HM, Lautenbach E, Bilker WB, Coffin SE. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J. 2004, 23:635-41. 10.1097\/01.inf.0000128781.77600.6f","journal-title":"Pediatr Infect Dis J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12288","article-title":"Candidaemia in a paediatric centre and importance of central venous catheter removal","volume":"58","author":"Karadag-Oncel E","year":"2015","unstructured":"Karadag-Oncel E, Kara A, Ozsurekci Y, et al.. Candidaemia in a paediatric centre and importance of central venous catheter removal. Mycoses. 2015, 58:140-8. 10.1111\/myc.12288","journal-title":"Mycoses"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piv048","article-title":"Central venous catheter retention and mortality in children with candidemia: a retrospective cohort analysis","volume":"5","author":"Fisher BT","year":"2016","unstructured":"Fisher BT, Vendetti N, Bryan M, et al.. Central venous catheter retention and mortality in children with candidemia: a retrospective cohort analysis. J Pediatric Infect Dis Soc. 2016, 5:403-8. 10.1093\/jpids\/piv048","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.87740","article-title":"Candida parapsilosis oral infection in an HIV-negative infant with profound CD4+ lymphopenia: unveiling a rare immunodeficiency scenario","volume":"17","author":"Filippatos F","year":"2025","unstructured":"Filippatos F, Karava V, Kakleas K, Santou A, Michos A. Candida parapsilosis oral infection in an HIV-negative infant with profound CD4+ lymphopenia: unveiling a rare immunodeficiency scenario. Cureus. 2025, 17:e87740. 10.7759\/cureus.87740","journal-title":"Cureus"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002010","article-title":"Risk factors for invasive fungal infection in children and adolescents with hematologic and malignant diseases: a 10-year analysis in a single institute in Japan","volume":"37","author":"Kobayashi R","year":"2018","unstructured":"Kobayashi R, Hori D, Sano H, Suzuki D, Kishimoto K, Kobayashi K. Risk factors for invasive fungal infection in children and adolescents with hematologic and malignant diseases: a 10-year analysis in a single institute in Japan. Pediatr Infect Dis J. 2018, 37:1282-5. 10.1097\/INF.0000000000002010","journal-title":"Pediatr Infect Dis J"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2012.06795.x","article-title":"The impact of azole resistance on aspergillosis guidelines","volume":"1272","author":"Georgiadou SP","year":"2012","unstructured":"Georgiadou SP, Kontoyiannis DP. The impact of azole resistance on aspergillosis guidelines. Ann N Y Acad Sci. 2012, 1272:15-22. 10.1111\/j.1749-6632.2012.06795.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0297590","article-title":"Mucormycosis in children with cancer and hematopoietic cell transplant-a single center cohort study","volume":"19","author":"Mar\u00f3n GA","year":"2024","unstructured":"Mar\u00f3n GA, Inagaki K, Rodriguez A, Knapp KM, Hayden RT, Adderson EE. Mucormycosis in children with cancer and hematopoietic cell transplant-a single center cohort study. PLoS One. 2024, 19:e0297590. 10.1371\/journal.pone.0297590","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/518612-profile-of-invasive-fungal-infections-in-a-paediatric-haemato-oncology-unit-a-five-year-retrospective-cohort-study-from-a-tertiary-care-centre-in-south-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:55:55Z","timestamp":1789030555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/518612-profile-of-invasive-fungal-infections-in-a-paediatric-haemato-oncology-unit-a-five-year-retrospective-cohort-study-from-a-tertiary-care-centre-in-south-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.116037","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}